WHO Prequalification-aligned sterile injectables manufacturing serving the SADC region with essential medicines
Partner With Us View Investment OpportunityAfriPharma Health Systems is pioneering pharmaceutical manufacturing in Africa, establishing WHO Prequalification-aligned facilities to address the region's critical dependence on imported medicines.
To strengthen pharmaceutical sovereignty across Africa by manufacturing high-quality, WHO-prequalified essential medicines locally, reducing import dependency and ensuring sustainable access to life-saving treatments for millions.
We are establishing state-of-the-art sterile injectables facilities in key African locations, starting with Mozambique and expanding to Botswana, with a focus on essential medicines that address infectious diseases, pain management, and pediatric care.
Seven WHO Essential Medicines List products addressing critical healthcare needs across infectious diseases, pain management, and pediatric care
Our unique pediatric paracetamol formulation addresses an $82M market gap, providing safe and effective pain management for children across the SADC region.
Essential antibiotics addressing the most common bacterial infections, aligned with WHO treatment guidelines and national formularies.
Life-saving emergency medications for acute care settings, seizure management, and anaphylactic reactions.
Creating sustainable health and economic outcomes across the SADC region
Reducing pharmaceutical import dependency from 88% to below 60% within 5 years, addressing supply chain vulnerabilities exposed by COVID-19.
Addressing critical pediatric formulation gaps for the 43% of SADC population under 15 years old with appropriate, age-specific medications.
Creating 150+ skilled local jobs with 40% women employment, contributing to economic development and technology transfer.
Reducing $50M annual import burden within 5 years while generating sustainable revenue and GDP contribution to the region.
Supporting UN Sustainable Development Goals including SDG 3 (Good Health), SDG 8 (Decent Work), and SDG 9 (Industry & Innovation).
Establishing Mozambique as a pharmaceutical manufacturing hub serving 380M people across the SADC region with quality medicines.
Join us in building Africa's pharmaceutical future with strong financial returns and measurable impact
Partner with us to transform healthcare in Africa